Australian company prepares for clinical milestones for its investigational technology designed to assess tissue during breast cancer surgery...
The crew of Artemis IV, planned for launch in 2028, will use MinION as part of their Microbiology of the Built Environment project...
The companies intend to leverage their complementary capabilities and geographic reach to bring ActraFlex to patients across multiple international markets...
Organised by IFAAS in collaboration with PASM, the two-day masterclass sold out six months in advance, reinforcing Singapore’s position as a regional hub for specialist medical education...
The combination of both heat and compression drives the therapeutic benefits deeper into the legs for a more amplified experience...
A groundbreaking, first-of-its-kind advancement marks a new era in reverse shoulder arthroplasty, culminating in eight years of US clinical investigation and regulatory development...
The ATB-2100 represents a new approach to advanced therapy processing, combining unprecedented process control and scalability in a fully closed and automated platform ...
The clearance follows a multicentre US investigation, adding a peripheral fixation option to the company’s shoulder reconstruction portfolio...
Catalyst was born from the experience that too many breakthrough innovations in healthcare never reach patients...
The analysis found that women and men with intermediate-risk pulmonary embolism (PE) experienced substantial clot burden reduction, improvements in right-heart function...